DOI QR코드

DOI QR Code

Associations of ERCC4 rs1800067 Polymorphism with Cancer Risk: an Updated Meta-analysis

  • Yuan, Quan (Tumor Etiology and Screening Department of Cancer Institute and General Surgery, the First Affiliated Hospital of China Medical University, and Key Laboratory of Cancer Etiology and Prevention (China Medical University), Liaoning Provincial Education Department) ;
  • Liu, Jing-Wei (Tumor Etiology and Screening Department of Cancer Institute and General Surgery, the First Affiliated Hospital of China Medical University, and Key Laboratory of Cancer Etiology and Prevention (China Medical University), Liaoning Provincial Education Department) ;
  • Xing, Cheng-Zhong (Tumor Etiology and Screening Department of Cancer Institute and General Surgery, the First Affiliated Hospital of China Medical University, and Key Laboratory of Cancer Etiology and Prevention (China Medical University), Liaoning Provincial Education Department) ;
  • Yuan, Yuan (Tumor Etiology and Screening Department of Cancer Institute and General Surgery, the First Affiliated Hospital of China Medical University, and Key Laboratory of Cancer Etiology and Prevention (China Medical University), Liaoning Provincial Education Department)
  • Published : 2014.10.11

Abstract

Background: Results from previous studies concerning the association of ERCC4 rs1800067 polymorphism with risk of cancer were inconsistent. To explore the exact relation with susceptibility, we conducted the present meta-analysis. Materials and Methods: Literature of electronic databases including PubMed, Web of Science, EMBASE, Wanfang and Chinese National Knowledge Infrastructure (CNKI) were systematically searched. ORs and their 95%CIs were used to assess the strength of associations between ERCC4 polymorphism and cancer risk. Results: There was no significant association between ERCC4 rs1800067 AA or AG genotypes and overall risk of cancer (AA vs. GG: OR=0.998, 95%CI=0.670-1.486, P=0.992; AG vs. GG: OR=0.970, 95%CI=0.888-1.061, P=0.508). A dominant genetic model also did not demonstrate significant association of (AA+AG) genotype carriers with altered risk of overall cancer (OR=0.985, 95%CI=0.909-1.068, P=0.719). In addition, no significant association was observed between A allele of ERCC4 rs1800067 A/G polymorphism and altered cancer risk compared with G allele (OR=0.952, 95%CI=0.851-1.063, P=0.381). Subgroup analysis suggested that AA genotype carriers were significantly associated with decreased risk of glioma compared with wild-type GG genotype individuals (OR=0.523, 95%CI=0.275-0.993, P=0.048). For subgroup of lung cancer, A allele of ERCC4 rs1800067 A/G polymorphism was significantly associated with decreased risk of lung cancer compared with G allele (OR=0.806, 95%CI=0.697-0.931, P=0.003). Conclusions: This meta-analysis indicated that ERCC4 rs1800067 A/G polymorphism might not be associated with risk of overall cancer. However, individuals with the AA genotype were associated with significantly reduced risk of glioma compared with wild-type GG genotype; The A allele was associated with significantly reduced risk of lung cancer compared with G allele. Future large-scale studies performed in multiple populations are warranted to confirm our results.

References

  1. Abbasi R, Ramroth H, Becher H, et al (2009). Laryngeal cancer risk associated with smoking and alcohol consumption is modified by genetic polymorphisms in ERCC5, ERCC6 and RAD23B but not by polymorphisms in five other nucleotide excision repair genes. Int J Cancer, 125, 1431-9. https://doi.org/10.1002/ijc.24442
  2. Agalliu I, Kwon EM, Salinas CA, et al (2010). Genetic variation in DNA repair genes and prostate cancer risk: results from a population-based study. Cancer Causes Control, 21, 289-300. https://doi.org/10.1007/s10552-009-9461-5
  3. Crew KD, Gammon MD, Terry MB, et al (2007). Polymorphisms in nucleotide excision repair genes, polycyclic aromatic hydrocarbon-DNA adducts, and breast cancer risk. Cancer Epidemiol Biomarkers Prev, 16, 2033-41. https://doi.org/10.1158/1055-9965.EPI-07-0096
  4. Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50, 1088-101. https://doi.org/10.2307/2533446
  5. Chang JS, Wrensch MR, Hansen HM, et al (2008). Nucleotide excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African Americans. Int J Cancer, 123, 2095-104. https://doi.org/10.1002/ijc.23801
  6. Cheng HB, Xie C, Zhang RY, et al (2013). Xeroderma pigmentosum complementation group F polymorphisms influence risk of glioma. Asian Pac J Cancer Prev, 14, 4083-7. https://doi.org/10.7314/APJCP.2013.14.7.4083
  7. de Laat WL, Jaspers NG, Hoeijmakers JH (1999). Molecular mechanism of nucleotide excision repair. Genes Dev, 13, 768-85. https://doi.org/10.1101/gad.13.7.768
  8. DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88. https://doi.org/10.1016/0197-2456(86)90046-2
  9. Ding DP, He XF, Zhang Y (2011). Lack of association between XPG Asp1104His and XPF Arg415Gln polymorphism and breast cancer risk: a meta-analysis of case-control studies. Breast Cancer Res Treat, 129, 203-9. https://doi.org/10.1007/s10549-011-1447-9
  10. Doherty JA, Weiss NS, Fish S, et al (2011). Polymorphisms in nucleotide excision repair genes and endometrial cancer risk. Cancer Epidemiol Biomarkers Prev, 20, 1873-82. https://doi.org/10.1158/1055-9965.EPI-11-0119
  11. Egger M, Davey Smith G, Schneider M, et al (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34. https://doi.org/10.1136/bmj.315.7109.629
  12. Enzlin JH, Scharer OD (2002). The active site of the DNA repair endonuclease XPF-ERCC1 forms a highly conserved nuclease motif. EMBO J, 21, 2045-53. https://doi.org/10.1093/emboj/21.8.2045
  13. Han J, Haiman C, Niu T, et al (2009). Genetic variation in DNA repair pathway genes and premenopausal breast cancer risk. Breast Cancer Res Treat, 115, 613-22. https://doi.org/10.1007/s10549-008-0089-z
  14. Fagbemi AF, Orelli B, Scharer OD (2011). Regulation of endonuclease activity in human nucleotide excision repair. DNA Repair, 10, 722-9. https://doi.org/10.1016/j.dnarep.2011.04.022
  15. Friedberg EC (2001). How nucleotide excision repair protects against cancer. Nat Rev Cancer, 1, 22-33. https://doi.org/10.1038/35094000
  16. Gil J, Ramsey D, Stembalska A, et al (2012). The C/A polymorphism in intron 11 of the XPC gene plays a crucial role in the modulation of an individual's susceptibility to sporadic colorectal cancer. Mol Biol Rep, 39, 527-34. https://doi.org/10.1007/s11033-011-0767-5
  17. Higgins JP, Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Stat Med, 21, 1539-58. https://doi.org/10.1002/sim.1186
  18. Huang WY, Berndt SI, Kang D, et al (2006). Nucleotide excision repair gene polymorphisms and risk of advanced colorectal adenoma: XPC polymorphisms modify smoking-related risk. Cancer Epidemiol Biomarkers Prev, 15, 306-11. https://doi.org/10.1158/1055-9965.EPI-05-0751
  19. Hung RJ, Christiani DC, Risch A, et al (2008). International lung cancer consortium: pooled analysis of sequence variants in DNA repair and cell cycle pathways. Cancer Epidemiol Biomarkers Prev, 17, 3081-9. https://doi.org/10.1158/1055-9965.EPI-08-0411
  20. Jorgensen TJ, Visvanathan K, Ruczinski I, et al (2007). Breast cancer risk is not associated with polymorphic forms of xeroderma pigmentosum genes in a cohort of women from Washington County, Maryland. Breast Cancer Res Treat, 101, 65-71. https://doi.org/10.1007/s10549-006-9263-3
  21. Joshi AD, Corral R, Siegmund KD, et al (2009). Red meat and poultry intake, polymorphisms in the nucleotide excision repair and mismatch repair pathways and colorectal cancer risk. Carcinogenesis, 30, 472-9. https://doi.org/10.1093/carcin/bgn260
  22. Kohlhase S, Bogdanova NV, Schurmann P, et al (2014). Mutation analysis of the ERCC4/FANCQ gene in hereditary breast cancer. PLoS One, 9, e85334. https://doi.org/10.1371/journal.pone.0085334
  23. Mantel N, Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48.
  24. Krupa R, Kasznicki J, Gajecka M, et al (2011). Polymorphisms of the DNA repair genes XRCC1 and ERCC4 are not associated with smoking- and drinking-dependent larynx cancer in a Polish population. Exp Oncol, 33, 55-6.
  25. Li Q, Wang JM, Peng Y, et al (2013). Association of DNA baseexcision repair XRCC1, OGG1 and APE1 gene polymorphisms with nasopharyngeal carcinoma susceptibility in a Chinese population. Asian Pac J Cancer Prev, 14, 5145-51. https://doi.org/10.7314/APJCP.2013.14.9.5145
  26. Lindahl T, Wood RD (1999). Quality control by DNA repair. Science, 286, 1897-905. https://doi.org/10.1126/science.286.5446.1897
  27. McWilliams RR, Bamlet WR, Cunningham JM, et al (2008). Polymorphisms in DNA repair genes, smoking, and pancreatic adenocarcinoma risk. Cancer Res, 68, 4928-35. https://doi.org/10.1158/0008-5472.CAN-07-5539
  28. Mechanic LE, Millikan RC, Player J, et al (2006). Polymorphisms in nucleotide excision repair genes, smoking and breast cancer in African Americans and whites: a population-based casecontrol study. Carcinogenesis, 27, 1377-85. https://doi.org/10.1093/carcin/bgi330
  29. Moreno V, Gemignani F, Landi S, et al (2006). Polymorphisms in genes of nucleotide and base excision repair: risk and prognosis of colorectal cancer. Clin Cancer Res, 12, 2101-8. https://doi.org/10.1158/1078-0432.CCR-05-1363
  30. Niedernhofer LJ, Odijk H, Budzowska M, et al (2004). The structure-specific endonuclease Ercc1-Xpf is required to resolve DNA interstrand cross-link-induced double-strand breaks. Mol Cell Biol, 24, 5776-87. https://doi.org/10.1128/MCB.24.13.5776-5787.2004
  31. Nouspikel T (2009). DNA repair in mammalian cells : Nucleotide excision repair: variations on versatility. Cell Mol Life Sci, 66, 994-1009. https://doi.org/10.1007/s00018-009-8737-y
  32. Shi TY, He J, Qiu LX, et al (2012). Association between XPF polymorphisms and cancer risk: a meta-analysis. PLoS One, 7, e38606. https://doi.org/10.1371/journal.pone.0038606
  33. Rajaraman P, Bhatti P, Doody MM, et al (2008). Nucleotide excision repair polymorphisms may modify ionizing radiationrelated breast cancer risk in US radiologic technologists. Int J Cancer, 123, 2713-6. https://doi.org/10.1002/ijc.23779
  34. Rajaraman P, Hutchinson A, Wichner S, et al (2010). DNA repair gene polymorphisms and risk of adult meningioma, glioma, and acoustic neuroma. Neuro Oncol, 12, 37-48. https://doi.org/10.1093/neuonc/nop012
  35. Santos LS, Gomes BC, Gouveia R, et al (2013). The role of CCNH Val270Ala (rs2230641) and other nucleotide excision repair polymorphisms in individual susceptibility to welldifferentiated thyroid cancer. Oncol Rep, 30, 2458-66.
  36. Smith TR, Levine EA, Perrier ND, et al (2003). DNA-repair genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev, 12, 1200-4.
  37. Smith TR, Liu-Mares W, Van Emburgh BO, et al (2011). Genetic polymorphisms of multiple DNA repair pathways impact age at diagnosis and TP53 mutations in breast cancer. Carcinogenesis, 32, 1354-60. https://doi.org/10.1093/carcin/bgr117
  38. Steck SE, Butler LM, Keku T, et al (2014). Nucleotide excision repair gene polymorphisms, meat intake and colon cancer risk. Mutat Res Fundam Mol Mech Mutagen, 762, 24-31. https://doi.org/10.1016/j.mrfmmm.2014.02.004
  39. Wang XF, Liu S, Shao ZK (2013). Effects of polymorphisms in nucleotide excision repair genes on glioma risk in a Chinese population. Gene, 529, 317-20. https://doi.org/10.1016/j.gene.2013.07.025
  40. Wei Q, Wang LE, Sturgis EM, et al (2005). Expression of nucleotide excision repair proteins in lymphocytes as a marker of susceptibility to squamous cell carcinomas of the head and neck. Cancer Epidemiol Biomarkers Prev, 14, 1961-6. https://doi.org/10.1158/1055-9965.EPI-05-0101
  41. Wyss AB, Herring AH, Avery CL, et al (2013). Single-nucleotide polymorphisms in nucleotide excision repair genes, cigarette smoking, and the risk of head and neck cancer. Cancer Epidemiol Biomarkers Prev, 22, 1428-45. https://doi.org/10.1158/1055-9965.EPI-13-0185
  42. Yang B, Chen WH, Wen XF, et al (2013). Role of DNA repairrelated gene polymorphisms in susceptibility to risk of prostate cancer. Asian Pac J Cancer Prev, 14, 5839-42. https://doi.org/10.7314/APJCP.2013.14.10.5839
  43. Yu H, Liu Z, Huang YJ, et al (2012). Association between single nucleotide polymorphisms in ERCC4 and risk of squamous cell carcinoma of the head and neck. PLoS One, 7, e41853. https://doi.org/10.1371/journal.pone.0041853

Cited by

  1. A Comprehensive Meta-analysis of Genetic Associations Between Key Polymorphic Loci in DNA Repair Genes and Glioma Risk vol.54, pp.2, 2017, https://doi.org/10.1007/s12035-016-9725-5